The Effect of Menopause on Antipsychotic Response
González-Rodríguez, Alexandre ![ORCID Identifier](/img/uab/orcid.ico)
(Hospital Universitari MútuaTerrassa)
Monreal, José Antonio ![ORCID Identifier](/img/uab/orcid.ico)
(Universitat Autònoma de Barcelona. Institut de Neurociències)
Seeman, Mary ![ORCID Identifier](/img/uab/orcid.ico)
(University of Toronto)
Date: |
2022 |
Abstract: |
Background: It has been hypothesized that, whenever estrogen levels decline, psychosis symptoms in women increase. At menopause, this can happen in two main ways: (a) the loss of estrogen (mainly estradiol) can directly affect central neurotransmission, leading to increase in schizophrenia-related symptoms, and (b) the loss of estrogen can decrease the synthesis of enzymes that metabolize antipsychotic drugs, thus weakening their efficacy. Aims and Methods: The aim of this narrative review was to investigate the second possibility by searching PubMed and ClinicalTrials. gov for studies over the last two decades that investigated the metabolism of antipsychotics and their efficacy before and after menopause in women or that studied systemic and local estrogen level effects on the pharmacokinetics and pharmacodynamics of individual antipsychotic drugs. Results: The evidence suggests that symptom level in women with schizophrenia rises after menopause for many reasons beyond hormones but, importantly, there is an estrogen-dependent loss of efficacy related to antipsychotic treatment. Conclusion: Effective clinical intervention is challenging; nevertheless, several promising routes forward are suggested. |
Rights: |
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. ![Creative Commons](/img/licenses/by.ico) |
Language: |
Anglès |
Document: |
Ressenya ; recerca ; Versió publicada |
Subject: |
Antipsychotics ;
Drug metabolism ;
Menopause ;
Schizophrenia |
Published in: |
Brain sciences, Vol. 12 Núm. 10 (october 2022) , p. 1342, ISSN 2076-3425 |
DOI: 10.3390/brainsci12101342
PMID: 36291276
The record appears in these collections:
Research literature >
UAB research groups literature >
Research Centres and Groups (research output) >
Health sciences and biosciences >
Institut de Neurociències (INc)Articles >
Research articlesArticles >
Published articlesArticles >
Reviews
Record created 2024-05-15, last modified 2024-06-20